Fatal COVID-19 in an MS patient on natalizumab: A case report

We report a fatal case of COVID-19 in a 51-year-old African American woman with multiple sclerosis on natalizumab. She had multiple risk factors for severe COVID-19 disease including race, obesity, hypertension, and elevated inflammatory markers, but the contribution of natalizumab to her poor outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Rimmer, Kathryn, Farber, Rebecca, Thakur, Kiran, Braverman, Genna, Podolsky, Dina, Sutherland, Lauren, Migliore, Christopher, Ryu, Yun Kyoung, Levin, Seth, De Jager, Philip L, Vargas, Wendy, Levine, Libby, Riley, Claire S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425275/
https://www.ncbi.nlm.nih.gov/pubmed/32850133
http://dx.doi.org/10.1177/2055217320942931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425275/
https://www.ncbi.nlm.nih.gov/pubmed/32850133
http://dx.doi.org/10.1177/2055217320942931

Ejemplares similares